{"id":70965,"date":"2025-11-03T08:11:10","date_gmt":"2025-11-03T08:11:10","guid":{"rendered":"https:\/\/www.europesays.com\/se\/70965\/"},"modified":"2025-11-03T08:11:10","modified_gmt":"2025-11-03T08:11:10","slug":"okad-forskrivning-av-narkotikaklassad-adhd-medicin-e-halsomyndigheten","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/70965\/","title":{"rendered":"\u00d6kad f\u00f6rskrivning av narkotikaklassad ADHD-medicin \u2022 E-h\u00e4lsomyndigheten"},"content":{"rendered":"<p class=\"lead\">&#13;<br \/>\n                        F\u00f6rskrivningen av lisdexamfetamin har f\u00f6rdubblats under perioden 2020 till 2024. D\u00e4rmed har det totala f\u00f6rs\u00e4ljningsv\u00e4rdet av narkotikaklassade l\u00e4kemedel \u00f6kat med 20 procent under perioden, visar E-h\u00e4lsomyndigheten i en f\u00e4rsk rapport.&#13;\n                    <\/p>\n<p>                    &#13;<br \/>\n    <img decoding=\"async\" src=\"https:\/\/www.europesays.com\/se\/wp-content\/uploads\/2025\/11\/okning-forsalj-adhd-med_2.png\" alt=\"Pil i diagram som visar en tjugoprocentig \u00f6kning mellan 2020 och 2024\"\/>&#13;<\/p>\n<p>I rapporten \u201dDetaljhandel med l\u00e4kemedel 2024\u201d framg\u00e5r att f\u00f6rskrivningen av narkotikaklassade l\u00e4kemedel uppgick till 2,8 miljarder kronor, vilket \u00e4r en \u00f6kning med 8,5 procent j\u00e4mf\u00f6rt med 2023 och 20,4 procent j\u00e4mf\u00f6rt med 2020. \u00d6kningen beror till stor del p\u00e5 \u00f6kad f\u00f6rskrivning av lisdexamfetamin som anv\u00e4nds framf\u00f6r allt f\u00f6r att behandla ADHD.<\/p>\n<p>Rapporten redovisar statistik \u00f6ver f\u00f6rs\u00e4ljning av l\u00e4kemedel till m\u00e4nniskor och djur, b\u00e5de f\u00f6rskrivning, rekvisition inom v\u00e5rden samt egenv\u00e5rdsl\u00e4kemedel. Ut\u00f6ver detta analyseras prisutvecklingen f\u00f6r l\u00e4kemedel sedan 2005 samt f\u00f6rs\u00e4ljning av generiska l\u00e4kemedel i ett internationellt perspektiv.<\/p>\n<p>            Om rapporten<\/p>\n<p>Rapporten \u201dDetaljhandel med l\u00e4kemedel\u201d \u00e4r en \u00e5rlig sammanst\u00e4llning som E\u2011h\u00e4lsomyndigheten g\u00f6r baserad p\u00e5 nationell statistik \u00a0\u00f6ver f\u00f6rs\u00e4ljningsuppgifter fr\u00e5n svenska \u00f6ppenv\u00e5rdsapotek och f\u00f6rs\u00e4ljningsst\u00e4llen f\u00f6r vissa receptfria l\u00e4kemedel.<\/p>\n<p>Myndigheter, regioner, f\u00f6retag, sjukv\u00e5rd, forskare, media med flera anv\u00e4nder statistiken f\u00f6r att f\u00f6lja l\u00e4kemedelsf\u00f6rs\u00e4ljningen i Sverige. Att sammanst\u00e4lla statistiken ing\u00e5r i E\u2011h\u00e4lsomyndighetens uppdrag.<\/p>\n<p>                &#13;<br \/>\n                    &#13;<\/p>\n","protected":false},"excerpt":{"rendered":"&#13; F\u00f6rskrivningen av lisdexamfetamin har f\u00f6rdubblats under perioden 2020 till 2024. D\u00e4rmed har det totala f\u00f6rs\u00e4ljningsv\u00e4rdet av narkotikaklassade&hellip;\n","protected":false},"author":2,"featured_media":70966,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[69],"tags":[113,112,34,31,33,32,30],"class_list":{"0":"post-70965","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-halsa","8":"tag-halsa","9":"tag-health","10":"tag-se","11":"tag-svenska","12":"tag-sverige","13":"tag-sweden","14":"tag-swedish"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/115484759416865981","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/70965","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=70965"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/70965\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/70966"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=70965"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=70965"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=70965"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}